Join ASGCT and save up to $350 on Annual Meeting registration!
Learn more about sessions and presentations at the 26th Annual Meeting
Saturday, May 20 2023 10:15 AM – 12:00 PM PT
Transfer RNAs (tRNA) play a critical role in decoding mRNAs into proteins. These small ~76-90 nt RNA molecules function as cellular couriers and bring a specific amino acid to the ribosome complex that corresponds to the intended mRNA codon. A growing body of evidence implicates that engineered tRNAs can be used as therapeutic molecules to suppress premature stop codons and insert functional amino acids. In addition, emerging data suggest a pathobiological role of fragmented tRNAs in human diseases. This session will cover a range of topics from genetics of tRNAs to their pathophysiology and therapeutic use.
10:15 AM – 12:00 PM - Room 515 AB
Mark A.. Kay, MD, PhD. Stanford University School of Medicine, Stanford, CA
Paloma H.. Giangrande, PhD. Wave Life Sciences, Cambridge, MA
10:16 AM – 10:40 AM - Room 515 AB
Todd M. Lowe, PhD. University of California Santa Cruz, CA
10:40 AM – 11:05 AM - Room 515 AB
Saumya Das, MD, PhD. Massachusetts General Hospital, Boston, MA
11:05 AM – 11:30 AM - Room 515 AB
Theonie Anastassiadis. Alltrna, MA, Flagship Pioneering, MA
11:30 AM – 11:55 AM - Room 515 AB
Christopher Ahern, PhD. University of Iowa, IA
© 2000-2023 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico